Follow Us

News Details

Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO

About Catalyst Pharmaceuticals, Inc.
  • NASDAQ: $CPRX
  • Notified: $4.15
  • 09:02 EDT

Price Chart